Stay updated with breaking news from Abstracts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and... | May 17, 2023
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline ... | May 8, 2023
LYON, France and CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
Oral presentation on SAR'579 IPH6101, a potential first-in-class NKp46/CD16-based NK cell engager targeting CD123; SAR'579 IPH6101 is ANKET platform lead asset and under development by partner Sanofi
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate... | May 1, 2023